In the hospital settings, the implementation of GLP-1RAs may be particularly challenging, especially with once-weekly formulations, due to the potential need for discontinuation before surgical or diagnostic procedures or in the event of clinical deterioration
Incorporating a semaglutide oral dose for weight loss has shown promising outcomes in clinical trials, offering an effective solution for individuals who have struggled with inadequate results from traditional methods
Beyond patient safety concerns, the study contends that widespread unauthorized compounding could reduce pharmaceutical research and development investment
Schubert S, Schwertz H, Weyrich AS, Franks ZG, Lindemann S, Otto M, Behr H, Loppnow H, Schlitt A, Russ M, Presek P, Werdan K, Buerke M